Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,789 | 688 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,899 | 124 | $0 (2024) |
| ABBVIE INC. | $1,320 | 75 | $0 (2024) |
| PFIZER INC. | $917.71 | 59 | $0 (2024) |
| Merck Sharp & Dohme LLC | $850.96 | 56 | $0 (2024) |
| Lilly USA, LLC | $765.86 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $737.48 | 38 | $0 (2024) |
| Amgen Inc. | $503.09 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $471.73 | 27 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $419.30 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $359.44 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,426 | 76 | Novo Nordisk Inc ($241.83) |
| 2023 | $1,711 | 90 | Novo Nordisk Inc ($397.77) |
| 2022 | $1,386 | 81 | Novo Nordisk Inc ($241.45) |
| 2021 | $1,749 | 98 | AbbVie Inc. ($425.37) |
| 2020 | $1,433 | 85 | AstraZeneca Pharmaceuticals LP ($199.60) |
| 2019 | $1,243 | 80 | Novo Nordisk Inc ($273.81) |
| 2018 | $1,839 | 111 | Merck Sharp & Dohme Corporation ($297.60) |
| 2017 | $1,002 | 67 | Merck Sharp & Dohme Corporation ($229.77) |
All Payment Transactions
688 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes Care | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Biological | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Oncology | ||||||
| 11/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: PAIN | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.55 | General |
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Bone Health | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 6,498 | 9,640 | $713,265 | $230,536 |
| 2022 | 48 | 6,411 | 8,965 | $685,175 | $254,776 |
| 2021 | 54 | 6,830 | 9,314 | $670,790 | $265,906 |
| 2020 | 48 | 6,414 | 8,894 | $652,823 | $231,853 |
All Medicare Procedures & Services
199 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 469 | 946 | $236,500 | $57,591 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 263 | 263 | $60,490 | $35,634 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 389 | 556 | $94,520 | $23,236 | 24.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 166 | 167 | $15,865 | $11,995 | 75.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 557 | 1,005 | $35,175 | $10,384 | 29.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 581 | 1,163 | $17,445 | $9,729 | 55.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 419 | 493 | $24,650 | $8,115 | 32.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 448 | 584 | $23,360 | $7,652 | 32.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 552 | 997 | $34,895 | $7,561 | 21.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 29 | $16,820 | $6,735 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $18,620 | $5,818 | 31.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 170 | 171 | $9,405 | $5,558 | 59.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 139 | 150 | $13,500 | $4,352 | 32.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 219 | 235 | $12,925 | $4,235 | 32.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 22 | $9,020 | $3,716 | 41.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 215 | 371 | $11,130 | $3,516 | 31.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 39 | 58 | $6,960 | $2,346 | 33.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 111 | 153 | $6,120 | $2,044 | 33.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 119 | 129 | $5,805 | $1,893 | 32.6% |
| 82746 | Folic acid level, serum | Office | 2023 | 122 | 131 | $5,895 | $1,875 | 31.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 29 | 30 | $4,500 | $1,702 | 37.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 99 | $4,950 | $1,429 | 28.9% |
| 83550 | Iron binding capacity | Office | 2023 | 112 | 154 | $4,620 | $1,320 | 28.6% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 130 | 155 | $3,100 | $1,043 | 33.7% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 23 | 23 | $1,495 | $996.82 | 66.7% |
About Dr. John Billon, MD
Dr. John Billon, MD is a Family Medicine healthcare provider based in Arnold, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083714653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Billon, MD has received a total of $11,789 in payments from pharmaceutical and medical device companies, with $1,426 received in 2024. These payments were reported across 688 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($11,789).
As a Medicare-enrolled provider, Billon has provided services to 26,153 Medicare beneficiaries, totaling 36,813 services with total Medicare billing of $983,071. Data is available for 4 years (2020–2023), covering 199 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Arnold, MD
- Active Since 09/24/2006
- Last Updated 11/10/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083714653
Products in Payments
- Ozempic (Drug) $728.71
- FARXIGA (Drug) $481.16
- XIFAXAN (Drug) $437.85
- UBRELVY (Drug) $396.37
- ELIQUIS (Drug) $392.64
- Rybelsus (Drug) $373.90
- JARDIANCE (Drug) $359.31
- LINZESS (Drug) $338.53
- Saxenda (Drug) $335.48
- TRULICITY (Drug) $295.39
- VRAYLAR (Drug) $261.00
- BELSOMRA (Drug) $249.02
- Aimovig (Biological) $238.61
- Vascepa (Drug) $233.84
- Kerendia (Drug) $228.19
- JANUVIA (Drug) $218.31
- SHINGRIX (Biological) $203.31
- Cologuard Collection Kit (Device) $187.97
- CREON (Drug) $183.61
- FREESTYLE LIBRE 3 (Device) $179.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Arnold
Dr. Victor Plavner, M.d, M.D
Family Medicine — Payments: $22,311
Dr. Christopher Abercrombie, Do, DO
Family Medicine — Payments: $17,803
Mirha Avdagic, M.d, M.D
Family Medicine — Payments: $4,651
Ashwinkumar Joshi, M.d, M.D
Family Medicine — Payments: $4,274
Dr. Mary Chitwood, Md, MD
Family Medicine — Payments: $2,523
Sanjay Sharma, Do, DO
Family Medicine — Payments: $2,517